LIPOPROTEIN(A), APOLIPOPROTEIN(A) POLYMORPHISM, AND INSULIN-TREATMENT IN TYPE-II DIABETIC-PATIENTS

被引：10
作者：
BUSCAGLIA, P
GAZZARUSO, C
GARZANITI, A
BONETTI, G
FRATINO, P
GEROLDI, D
机构：
[1] POLICLIN SAN MATTEO,IRCCS,DEPT INTERNAL MED & MED THERAPEUT,MED CLIN 1,I-27100 PAVIA,ITALY
[2] UNIV PAVIA,POLO UNIV CITTA PAVIA,DEPT INTERNAL MED & MED THERAPEUT,I-27100 PAVIA,ITALY
来源：
DIABETES CARE | 1995年 / 18卷 / 08期
关键词：
D O I：
10.2337/diacare.18.8.1202
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1202 / 1203
页数：2
相关论文
共 4 条
[1]   CHARACTERIZATION OF APO(A) POLYMORPHISM BY A MODIFIED IMMUNOBLOTTING TECHNIQUE IN AN ITALIAN POPULATION-SAMPLE [J].
GEROLDI, D ;
BELLOTTI, V ;
BUSCAGLIA, P ;
BONETTI, G ;
GAZZARUSO, C ;
CAPRIOLI, A ;
FRATINO, P .
CLINICA CHIMICA ACTA, 1993, 221 (1-2) :159-169
[2]   LIPOPROTEIN(A) AND INSULIN-TREATMENT IN NIDDM PATIENTS [J].
GRUDEN, G ;
VEGLIO, M ;
CAVALLOPERIN, P ;
OLIVETTI, C ;
MORMILE, A ;
CASSADER, M ;
PAGANO, G .
DIABETES CARE, 1994, 17 (09) :1075-1076
[3]   APOLIPOPROTEINS (A-I, A-II, B), LP(A) LIPOPROTEIN AND LECITHIN-CHOLESTEROL ACYLTRANSFERASE ACTIVITY IN DIABETES-MELLITUS [J].
SCHERNTHANER, G ;
KOSTNER, GM ;
DIEPLINGER, H ;
PRAGER, R ;
MUHLHAUSER, I .
ATHEROSCLEROSIS, 1983, 49 (03) :277-293
[4]   IMPROVED BLOOD-GLUCOSE CONTROL BY INSULIN THERAPY IN TYPE-2 DIABETIC-PATIENTS HAS NO EFFECT ON LIPOPROTEIN(A) LEVELS [J].
WOLFFENBUTTEL, BHR ;
LEURS, PB ;
SELS, JPJE ;
RONDASCOLBERS, GJWM ;
MENHEERE, PPCA ;
KRUSEMAN, ACN .
DIABETIC MEDICINE, 1993, 10 (05) :427-430
1